Bakkt Holdings Overview
Latest ROE for Bakkt Holdings: -8.66% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-8.66%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for VIH is -8.66%. That is below the sector sector average of -5.68%. Investors often review this figure alongside Bakkt Holdings's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, VIH currently prints -8.66% for ROE, while the sector average sits near -5.68%. That is roughly 52.4% below the sector mean. Large gaps often invite a closer look at Bakkt Holdings's growth, margins, and balance sheet.
Return on Equity shows how effectively Bakkt Holdings converts resources into returns. At -8.66%, VIH may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting VIH's ROE (-8.66%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
